In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: ScanSource’s current price exceeds the PERT-weighted fair value by 16.2%, indicating potential overvaluation. Monte Carlo analysis shows substantial downside risk, with all scenarios below current price and a high volatility coefficient. Strong leverage and low growth scores highlight financial strain despite good liquidity.